To validate the differential expression of B7-H3 in normal tissue and RMS tumors, we first evaluated the sensitivity and specificity of four commercial antibodies using tumor xenografts of RMS wild-type and knockout cells for B7-H3 (Figure S3). The gene discussed is CD276; the disease is neoplasm.